Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
845.72
+2.09 (0.25%)
At close: Oct 8, 2025, 4:00 PM EDT
845.20
-0.52 (-0.06%)
After-hours: Oct 8, 2025, 6:04 PM EDT
Eli Lilly Stock Forecast
Stock Price Forecast
The 16 analysts that cover Eli Lilly stock have a consensus rating of "Strong Buy" and an average price target of $969.56, which forecasts a 14.64% increase in the stock price over the next year. The lowest target is $700 and the highest is $1,190.
Price Target: $969.56 (+14.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eli Lilly stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 10 | 9 | 9 | 9 |
| Buy | 7 | 7 | 7 | 6 | 5 | 5 |
| Hold | 0 | 0 | 0 | 1 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 19 | 18 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $875 → $948 | Strong Buy | Maintains | $875 → $948 | +12.09% | Oct 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,028 → $1,023 | Buy | Maintains | $1,028 → $1,023 | +20.96% | Oct 3, 2025 |
| Berenberg | Berenberg | Strong Buy → Hold Downgrades $970 → $830 | Strong Buy → Hold | Downgrades | $970 → $830 | -1.86% | Sep 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $1,100 → $1,050 | Buy | Maintains | $1,100 → $1,050 | +24.15% | Sep 16, 2025 |
| HSBC | HSBC | Sell → Hold Upgrades $675 → $700 | Sell → Hold | Upgrades | $675 → $700 | -17.23% | Aug 27, 2025 |
Financial Forecast
Revenue This Year
62.31B
from 45.04B
Increased by 38.34%
Revenue Next Year
73.76B
from 62.31B
Increased by 18.38%
EPS This Year
22.95
from 11.71
Increased by 95.98%
EPS Next Year
30.35
from 22.95
Increased by 32.24%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 65.4B | 82.2B | |||
| Avg | 62.3B | 73.8B | |||
| Low | 59.3B | 65.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 45.2% | 31.8% | |||
| Avg | 38.3% | 18.4% | |||
| Low | 31.7% | 5.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.66 | 34.65 | |||
| Avg | 22.95 | 30.35 | |||
| Low | 21.50 | 26.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 110.6% | 51.0% | |||
| Avg | 96.0% | 32.2% | |||
| Low | 83.6% | 17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.